Oncotelic Therapeutics, Inc.
OTLC· OTC
OTLCOncotelic Therapeutics, Inc.
Filed Apr 14, 2023 · 10-K · 104 days after period end · 0001493152-23-012352
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | — | $0.00 | — |
| Net Income | -$5.29M | -$1.79M | -$3.44M | -$3.48M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oncotelic Therapeutics, Inc. · CIK 908259 · Engraved from SEC EDGAR
ended Dec 31, 2022 · filed Apr 14, 2023 · 104 d after period end
